Showing 1 - 20 results of 690 for search '(( strains ((((reported decrease) OR (we decrease))) OR (nn decrease)) ) OR ( _ team decrease ))', query time: 0.41s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Development of a CRISPR/Cas-Based Detection Platform for Tracking Decreased Susceptibility to Cephalosporins in Neisseria gonorrheae by Ziyuan Zhao (2889005)

    Published 2025
    “…We have developed the Multiplex Integrated RPA-CRISPR/Cas12a detection Assay (MIRCA) for simultaneous detection of Neisseria gonorrheae (<i>Ng</i>) and mutations with decreased susceptibility to cephalosporins. …”
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Bacterial strains and plasmids. by Eunsil Choi (8271039)

    Published 2025
    “…This functional attenuation was corroborated by the decrease in virulence observed in the 14028Δ<i>bipA</i> strain in a mouse model. …”
  10. 10

    Strains used in this study. by Zachary T. Hying (21512605)

    Published 2025
    “…In strains lacking <i>efgA</i>, we showed that inflated intracellular formaldehyde pools were accompanied by decreased cell viability, while the loss of <i>ttmR</i> resulted in the loss of one-carbon metabolites to the extracellular space. …”
  11. 11
  12. 12
  13. 13

    Project summary: Team Based Learning tutorials in S248 by Kate Nixon (18466555)

    Published 2024
    “…The project will implement some elements of the team-based learning (TBL) approach<sup>1</sup> to deliver tutorials with a greater student focus and an emphasis on building working relationships with members of a team. …”
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Conformational Role of Methyl in the Potency of Cyclohexane-Substituted Squaramide CCR6 Antagonists by Brian S. Gerstenberger (1936534)

    Published 2025
    “…CCR6 is a chemokine receptor that mediates the migration of pathogenic inflammatory leukocytes to sites of inflammation in response to its ligand, CCL20. Herein we report the design of a potent CCR6 antagonist capable of inhibiting the chemotactic migration of CCR6<sup>+</sup> T cells in vitro. …”
  20. 20

    Conformational Role of Methyl in the Potency of Cyclohexane-Substituted Squaramide CCR6 Antagonists by Brian S. Gerstenberger (1936534)

    Published 2025
    “…CCR6 is a chemokine receptor that mediates the migration of pathogenic inflammatory leukocytes to sites of inflammation in response to its ligand, CCL20. Herein we report the design of a potent CCR6 antagonist capable of inhibiting the chemotactic migration of CCR6<sup>+</sup> T cells in vitro. …”